Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner.
about
Interleukin (IL)-25: Pleiotropic roles in asthmaBryostatin improves survival and reduces ischemic brain injury in aged rats after acute ischemic strokeA knowledgebase resource for interleukin-17 family mediated signalingEffects of neonatal systemic inflammation on blood-brain barrier permeability and behaviour in juvenile and adult ratsTh 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity.Molecular analysis of interleukin-25 exons 1 and 2 and its serum levels in Iranian patients with multiple sclerosis.The blood-brain barrier in health and disease.A derivative of L-allo threonine alleviates 2,4-dinitrofluorobenzene-induced atopic dermatitis indications.IL-1β suppresses innate IL-25 and IL-33 production and maintains helminth chronicity.Interleukin-1β induces blood-brain barrier disruption by downregulating Sonic hedgehog in astrocytes.Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells.Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokinesEotaxin-Rich Proangiogenic Hematopoietic Progenitor Cells and CCR3+ Endothelium in the Atopic Asthmatic Response.Interleukin-25 is detrimental for recovery after spinal cord injury in mice.12/15-Lipoxygenase mediates high-fat diet-induced endothelial tight junction disruption and monocyte transmigration: a new role for 15(S)-hydroxyeicosatetraenoic acid in endothelial cell dysfunctionEzrin/radixin/moesin proteins differentially regulate endothelial hyperpermeability after thrombin.Inflammatory Disequilibrium in StrokeVascular endothelial tight junctions and barrier function are disrupted by 15(S)-hydroxyeicosatetraenoic acid partly via protein kinase C ε-mediated zona occludens-1 phosphorylation at threonine 770/772.IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells.Electroacupuncture Attenuates CFA-induced Inflammatory Pain by suppressing Nav1.8 through S100B, TRPV1, Opioid, and Adenosine Pathways in Mice.IL-17 family member cytokines: regulation and function in innate immunity.Signaling of interleukin-17 family cytokines in immunity and inflammation.Structure and function of interleukin-17 family cytokines.Cytokine pathways in allergic disease.Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation.Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver DiseasesHIV-1 Latency-Reversing Agents Prostratin and Bryostatin-1 Induce Blood-Brain Barrier Disruption/Inflammation and Modulate Leukocyte Adhesion/Transmigration.The epithelial barrier and immunoglobulin A system in allergy.Codon optimization, expression, purification, and functional characterization of recombinant human IL-25 in Pichia pastoris.IL-25 in allergic inflammation.MiR-34a regulates blood-tumor barrier function by targeting protein kinase Cε.Interleukin-25 Produced by Synoviocytes Has Anti-inflammatory Effects by Acting As a Receptor Antagonist for Interleukin-17A Function.IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.Organ-specific protection mediated by cooperation between vascular and epithelial barriers.Tumour necrosis factor-α-mediated disruption of cerebrovascular endothelial barrier integrity in vitro involves the production of proinflammatory interleukin-6.Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions.Inhibition of proinflammatory cytokine by IL-25 in Vogt-Koyanagi-Harada syndrome.The "Frail" Brain Blood Barrier in Neurodegenerative Diseases: Role of Early Disruption of Endothelial Cell-to-Cell Connections
P2860
Q26772165-B69AB950-4918-4779-99F5-3194D8818DA6Q28387089-F54A1B03-9090-4327-AD2E-3479ACA5CA71Q28607319-68A45C91-EB02-479E-97AD-E703B1111BCCQ30475556-05981EAB-87E0-4105-A0FC-B36632E13256Q33894387-84383A48-4992-4569-83B9-46BC6FA2FDFCQ34066491-A0A1C397-ED5F-497C-BF0C-573E4D69C510Q34320420-D8090875-D340-4AD4-BED9-EB62353D8AB6Q34468671-511B6DE1-CABB-49BE-915D-348CFEF3DF87Q34916928-3DEB3EEB-6583-45C5-99A5-F68ECD3DE024Q35330589-1E8D0819-DA4F-48A2-91FA-B8DE83B5BC85Q35533000-E90BD060-B4C3-4642-B541-B4DBF567B0CFQ36372950-2C7AE48A-423D-4958-894A-B516A9865AAFQ36601063-9F0466F5-E7E5-48F2-AC79-0B2E266F3DC9Q36876011-A6F326BF-FFC9-4ABE-8C29-1E4B02D757D9Q36890646-6C8B9CA5-6C13-4A5F-9CD3-88ACF946C96FQ37094211-98CD8209-3F64-4FE8-8542-B2A91C84C4FBQ37474699-CEA4CF74-DD3F-4D05-B28B-DFA77DCA2F8FQ37563388-226FAF73-3060-41F8-BFAB-2D73CFBF8C12Q37619759-160D4F6A-939C-442F-BFAA-4340FDFDAA49Q37637997-1AB1E596-0A55-4B75-896A-B0D5691DE3C0Q37809207-1D6DA084-2126-40F7-83FF-48A66C3D90B7Q37815900-ABE032D8-9DC4-43C3-9765-9B0A5838515EQ37845252-7523063B-F49A-4555-B43A-6FC8EC315F5EQ37981059-821C6E3D-509E-4F7E-BB07-27B4099301B6Q38058856-3CD34A2E-C3A5-4BC2-BB99-85D0C211EAE4Q38543052-4FF2B3A8-CAB1-46DB-919A-8A655A8035A0Q38725384-AE352E38-A9B5-45BE-A571-24045EE0997DQ38967737-7B56BDE1-ED48-48E3-B767-5508EAF0CBC7Q39084902-96ACC9B5-409D-4878-978C-2074F5D95F85Q39402916-1078E39A-A68F-444D-81A4-FFC279C76658Q40823291-7F9B0061-0E67-461E-A190-5200C2B9A066Q42236975-73725AC9-BF63-4D59-9ED1-C0D8E3C9844EQ43475176-6B2C14A4-BA54-4939-BA87-46C19B88C393Q46312498-B3772436-5A47-4DE2-AE66-8BD854E9979CQ46649192-C218FED1-6C8B-4ABB-B2DC-333149633124Q52689036-D59536A8-D2DB-4FA0-B8A0-23B42FEF1C3DQ54453981-84B93764-A405-4EF4-8232-95791F399412Q58753178-E7EB2C2A-9185-494D-874B-13496EA989AD
P2860
Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Interleukin-25 expressed by br ...... ase Cepsilon-dependent manner.
@ast
Interleukin-25 expressed by br ...... ase Cepsilon-dependent manner.
@en
Interleukin-25 expressed by br ...... ase Cepsilon-dependent manner.
@nl
type
label
Interleukin-25 expressed by br ...... ase Cepsilon-dependent manner.
@ast
Interleukin-25 expressed by br ...... ase Cepsilon-dependent manner.
@en
Interleukin-25 expressed by br ...... ase Cepsilon-dependent manner.
@nl
prefLabel
Interleukin-25 expressed by br ...... ase Cepsilon-dependent manner.
@ast
Interleukin-25 expressed by br ...... ase Cepsilon-dependent manner.
@en
Interleukin-25 expressed by br ...... ase Cepsilon-dependent manner.
@nl
P2093
P2860
P921
P356
P1476
Interleukin-25 expressed by br ...... ase Cepsilon-dependent manner.
@en
P2093
Akio Suzumura
Hideyuki Takeuchi
Kunio Kataoka
Maya Mimuro
Shijie Jin
Takashi Kanda
Tetsuya Mizuno
Yasuteru Sano
Yoshifumi Sonobe
P2860
P304
31834-31842
P356
10.1074/JBC.M109.025940
P407
P577
2009-09-23T00:00:00Z